Sotera Health (NASDAQ:SHC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Sotera Health (NASDAQ:SHC) have been given an average rating of “Moderate Buy” by the seven ratings firms that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $16.08.

Several analysts have recently issued reports on SHC shares. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Citigroup boosted their price target on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Finally, The Goldman Sachs Group began coverage on Sotera Health in a report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price objective on the stock.

Institutional Investors Weigh In On Sotera Health

Institutional investors and hedge funds have recently modified their holdings of the stock. Price T Rowe Associates Inc. MD boosted its stake in shares of Sotera Health by 25.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 59,480 shares of the company’s stock valued at $715,000 after purchasing an additional 12,195 shares during the period. Comerica Bank increased its position in shares of Sotera Health by 20.1% during the first quarter. Comerica Bank now owns 48,179 shares of the company’s stock worth $579,000 after acquiring an additional 8,074 shares during the last quarter. CWM LLC lifted its stake in shares of Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after acquiring an additional 993 shares in the last quarter. Simplicity Wealth LLC purchased a new position in Sotera Health in the second quarter valued at about $128,000. Finally, Wedmont Private Capital acquired a new stake in Sotera Health during the 2nd quarter valued at approximately $127,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Down 1.9 %

Shares of Sotera Health stock opened at $13.15 on Monday. The business’s fifty day moving average is $14.61 and its two-hundred day moving average is $14.14. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.44. The firm has a market cap of $3.72 billion, a PE ratio of 52.60 and a beta of 1.96.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The company had revenue of $285.47 million for the quarter, compared to analysts’ expectations of $278.64 million. During the same quarter in the previous year, the company earned $0.18 earnings per share. The company’s revenue was up 8.5% on a year-over-year basis. Analysts anticipate that Sotera Health will post 0.61 earnings per share for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.